Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class | LM ID | Common Name | Systematic Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula ▲ |
---|---|---|---|---|---|---|---|---|---|---|
Acidic glycosphingolipids
|
Gangliosides
|
GalNAc-GD1a(Neu5Gc/Neu5Ac)(d18:1/26:0)
|
GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
2168.17157
|
C100H177N5O45
|
|||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
2200.1614
|
C100H177N5O47
|
||||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
GalNAcalpha1-3Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
2216.156315
|
C100H177N5O48
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
VI 3GalNAca-IV 6kladoLcOse8(d18:1/20:0)
|
GalNAcalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
2216.156315
|
C100H177N5O48
|
|||||
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
2175.154918
|
C100H178N2O48
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type III A antigen(d18:1/22:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2171.171236
|
C100H178N4O46
|
|||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2187.166151
|
C100H178N4O47
|
||||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2187.166151
|
C100H178N4O47
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2187.166151
|
C100H178N4O47
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
Lex-9(d18:1/22:0)
|
Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2187.166151
|
C100H178N4O47
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01